...
首页> 外文期刊>BMC Infectious Diseases >Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections
【24h】

Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections

机译:肝硬化患者自发性细菌性腹膜炎的病因和转归:社区获得性与医院感染

获取原文
           

摘要

Spontaneous bacterial peritonitis (SBP) is a serious complication and common cause of death in patients with liver cirrhosis. This study was conducted to compare the microbiological characteristics, drug resistance, and treatment outcomes for nosocomial SBP and community-acquired SBP. A retrospective study was performed on 334 patients with culture-positive SBP at Beijing Youan Hospital, China, between January 2012 and December 2016. The medical records for these patients were reviewed, and their clinical and laboratory data were analyzed. A total of 155 (46.4%) patients with nosocomial SBP and 179 (53.6%) with community-acquired SBP were included in this study. From the patients’ ascitic fluids, 334 pathogenic strains, including 178 Gram-negative bacterial strains, 138 Gram-positive bacterial strains and 18 other microbial strains were isolated. E. coli was the major pathogen (24.3%), followed by Klebsiella pneumoniae (12.0%) and Enterococcus faecium (10.5%). The proportion of Enterococcus was significantly higher in the patients with nosocomial SBP (6.1% vs. 27.7%, P??0.001) than in the patients with community-acquired SBP. The main pathogens isolated from the nosocomial infections were significantly more resistant to the first-line recommended drug. Compared with community-acquired SBP, nosocomial SBP had a poorer outcome (36.8% vs. 24.6%; P?=?0.016). The independent predictors for 30-day mortality included nosocomial infection, Child-Pugh classification, hepatocellular carcinoma, renal failure and hepatic encephalopathy. Gram-negative bacteria were the major pathogens involved in SBP in the cirrhotic patients. The strains isolated from the patients with nosocomial SBP displayed higher drug resistance than those isolated from patients with community-acquired SBP. Compared with community-acquired SBP, nosocomial SBP had a poorer outcome. When choosing drug treatments, the acquisition site of infection and the local epidemiological situation should be taken into account.
机译:自发性细菌性腹膜炎(SBP)是肝硬化患者的严重并发症,是常见的死亡原因。这项研究的目的是比较医院内SBP和社区获得性SBP的微生物学特征,耐药性和治疗效果。回顾性研究于2012年1月至2016年12月在中国北京佑安医院对334例培养阳性的SBP患者进行了回顾性研究。对这些患者的病历进行了回顾,并对其临床和实验室数据进行了分析。这项研究共纳入155名(46.4%)的医院内SBP患者和179名(53.6%)的社区获得性SBP患者。从患者的腹水中分离出334种致病菌,包括178株革兰氏阴性菌,138株革兰氏阳性菌和18种其他微生物菌。大肠杆菌是主要病原体(24.3%),其次是肺炎克雷伯菌(12.0%)和粪肠球菌(10.5%)。医院SBP患者的肠球菌比例明显高于社区获得性SBP患者(6.1%vs. 27.7%,P <0.001)。从医院感染中分离出的主要病原体对一线推荐药物的耐药性明显更高。与社区获得性SBP相比,医院SBP的预后较差(36.8%对24.6%; P <= 0.016)。 30天死亡率的独立预测因素包括医院感染,Child-Pugh分类,肝细胞癌,肾衰竭和肝性脑病。肝炎患者中,革兰氏阴性细菌是参与SBP的主要病原体。从医院SBP患者中分离出的菌株比从社区获得性SBP患者中分离出的菌株表现出更高的耐药性。与社区获得性SBP相比,医院SBP的预后较差。选择药物治疗时,应考虑到感染的获得部位和当地的流行病学情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号